Verteporfin
-
Subject Areas on Research
- Adopting the Results of Everest II Into Practice: A Clearer View From a Higher Level Study.
- Adverse reaction characterized by chest pain, shortness of breath, and syncope associated with verteporfin (visudyne).
- Analysis of the heterogeneity of pO2 dynamics during photodynamic therapy with verteporfin.
- Antibody-targeted photodynamic therapy.
- Cost-effectiveness of Intravitreal Ranibizumab With Verteporfin Photodynamic Therapy Compared With Ranibizumab Monotherapy for Patients With Polypoidal Choroidal Vasculopathy.
- Driving ability reported by neovascular age-related macular degeneration patients after treatment with ranibizumab.
- Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial.
- Extracellular matrix and Hippo signaling as therapeutic targets of antifibrotic compounds for uterine fibroids.
- Functional changes after photodynamic therapy with verteporfin.
- Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumors.
- Macular translocation surgery with 360-degree peripheral retinectomy following ocular photodynamic therapy of choroidal neovascularization.
- Optical coherence tomography following photodynamic therapy with verteporfin for subfoveal predominantly classic choroidal neovascularization.
- Photodynamic therapy for predominantly hemorrhagic lesions in neovascular age-related macular degeneration.
- Photodynamic treatment in a rabbit model of glaucoma surgery.
- RADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia.
- Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration (FOCUS): year 2 results.
- Regression of extrafoveal choroidal osteoma following photodynamic therapy.
- Resolution of advanced cystoid macular edema following photodynamic therapy for choroidal hemangioma.
- Retrospective review of eyes with neovascular age-related macular degeneration treated with photodynamic therapy with verteporfin and intravitreal triamcinolone.
- THREE-YEAR RESULTS OF POLYPOIDAL CHOROIDAL VASCULOPATHY TREATED WITH PHOTODYNAMIC THERAPY: Retrospective Study and Systematic Review.
- YAP/TAZ Mediate TGFβ2-Induced Schlemm's Canal Cell Dysfunction.